An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits
Abstract Background Metformin hydrochloride is a biguanide derivative that has been widely used to treat type 2 diabetes in humans. In veterinary medicine, metformin has shown increasing potential for diabetes treatment in different species, such as equids, dogs, cats and rabbits. It is highly hydro...
Main Authors: | Sihem Bouriche, Angela Alonso-García, Carlos M. Cárceles-Rodríguez, Farouk Rezgui, Emilio Fernández-Varón |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12917-021-03016-3 |
Similar Items
-
Sustained released Metformin microparticles for better management of type II diabetes mellitus: in-vitro studies
by: Hina Raza, et al.
Published: (2020-01-01) -
Comparative Pharmacokinetic Study Among 3 Metformin Formulations in Healthy Mexican Volunteers: A Single-Dose, Randomized, Open-Label, 3-Period Crossover Study
by: Sandra Lucía Montoya-Eguía, DrC, et al.
Published: (2015-12-01) -
Predicting absorption and pharmacokinetic profile of carbamazepine from controlled-release tablet formulation in humans using rabbit model
by: Homšek Irena, et al.
Published: (2011-01-01) -
Characterization of Magnetic Polymeric Microparticles
by: Kazım Köse
Published: (2016-08-01) -
Sustained-releasing hollow microparticles with dual-anticancer drugs elicit greater shrinkage of tumor spheroids
by: Baek, Jong-Suep, et al.
Published: (2018)